Trial Profile
Sofosbuvir Plus Daclatasvir With or Without Ribavirin for Chronic Hepatitis C Infection: Impact of Drug Concentration on Viral Load Decay
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 28 Oct 2017 New trial record